Association of Estimated Glomerular Filtration Rate with Risk of Head and Neck Cancer: A Nationwide Population-Based Study

被引:0
作者
Kim, Hyun-Bum [1 ]
Park, Jun-Ook [1 ]
Nam, Inn-Chul [1 ]
Kim, Choung-Soo [1 ]
Park, Sung Joon [2 ]
Lee, Dong-Hyun [1 ]
Han, Kyungdo [3 ]
Joo, Young-Hoon [1 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul 06591, South Korea
[2] Chung Ang Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Gwangmyeong Hosp, Gwangmyeon Si 14353, South Korea
[3] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul 06978, South Korea
关键词
head and neck neoplasms; glomerular filtration rate; kidney disease; epidemiology; Korea; CHRONIC KIDNEY-DISEASE; EPIDEMIOLOGY; CKD;
D O I
10.3390/cancers14204976
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary A decreased estimated glomerular filtration rate is associated with several types of cancer. However, there are controversies regarding such an association between the estimated glomerular filtration rate and head and neck cancer. This is an observational cohort study using data from the Korean national health claims database. Elevated estimated glomerular filtration rate was associated with a risk of head and neck cancer incidence. In this study, through a cohort study of 10 million people, we investigated the association between estimated glomerular filtration rate (eGFR) and head and neck cancer (HNC) incidence. This is an observational cohort study using data from the national health claims database established by the Korean National Health Insurance Service (NHIS). We selected 9,598,085 participants older than 20 years who had undergone health checkups in 2009. A health checkup involves the history of any diseases, current health status, and results of several physical and blood exams including eGFR. We investigated the presence of HNC diagnosis in their national health insurance data from 2010 to 2018. Of the 9,598,085 participants, 10,732 had been newly diagnosed with HNC in the 9-year follow-up. In the multivariate Cox proportional hazard model, participants with elevated eGFR were associated with a risk of HNC incidence (HR = 1.129; 95% CI = 1.075-1.186 for eGFR = 90-104 mL/min/1.73 m(2) and HR = 1.129; 95% CI = 1.076-1.194 for eGFR >= 105 mL/min/1.73 m(2)) compared with those with eGFR 60-89 mL/min/1.73 m(2). Among HNC, the incidences of oral cavity, oropharyngeal, hypopharyngeal, and laryngeal cancers were significantly increased in the elevated eGFR group. According to the subgroup analysis, participants with eGFR >= 60 mL/min/1.73 m(2) were correlated with risk of HNC incidence in middle age, non/mild drinker, low BMI, no diabetes, and no hypertension patients compared with those with eGFR < 60 mL/min/1.73 m(2). Elevated eGFR was associated with the risk of some type of HNC, even in individuals with adjusted hypertension and diabetes without chronic diseases. The results of this study have implications for etiological investigations and preventive strategies.
引用
收藏
页数:11
相关论文
共 28 条
[2]  
[Anonymous], 2019, Am J Kidney Dis, DOI 10.1053/j.ajkd.2019.09.002
[3]   Head and Neck Cancers, Version 1.2022 Featured Updates to the NCCN Guidelines [J].
Caudell, Jimmy J. ;
Gillison, Maura L. ;
Maghami, Ellie ;
Spencer, Sharon ;
Pfister, David G. ;
Adkins, Douglas ;
Birkeland, Andrew C. ;
Brizel, David M. ;
Busse, Paul M. ;
Cmelak, Anthony J. ;
Colevas, A. Dimitrios ;
Eisele, David W. ;
Galloway, Thomas ;
Geiger, Jessica L. ;
Haddad, Robert, I ;
Hicks, Wesley L. ;
Hitchcock, Ying J. ;
Jimeno, Antonio ;
Leizman, Debra ;
Mell, Loren K. ;
Mittal, Bharat B. ;
Pinto, Harlan A. ;
Rocco, James W. ;
Rodriguez, Cristina P. ;
Savvides, Panayiotis S. ;
Schwartz, David ;
Shah, Jatin P. ;
Sher, David ;
St John, Maie ;
Weber, Randal S. ;
Weinstein, Gregory ;
Worden, Frank ;
Bruce, Justine Yang ;
Yom, Sue S. ;
Zhen, Weining ;
Burns, Jennifer L. ;
Darlow, Susan D. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (03) :224-234
[4]   Renin-angiotensin system inhibitor use and colorectal cancer risk and mortality: A dose-response meta analysis [J].
Chen, Xia ;
Yi, Chang-hong ;
Ya, Kuang-guan .
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2020, 21 (03)
[5]   Epidemiology of cancer in end-stage renal disease dialysis patients: a national cohort study in Taiwan [J].
Chien, Chih-Chiang ;
Han, Ming-Ming ;
Chiu, Yu-Hsien ;
Wang, Jhi-Joung ;
Chu, Chin-Chen ;
Hung, Chien-Ya ;
Sun, Yih-Min ;
Yeh, Nai-Cheng ;
Ho, Chung-Han ;
Lin, Chih-Ching ;
Kao, Hao-Yun ;
Weng, Shih-Feng .
JOURNAL OF CANCER, 2017, 8 (01) :9-18
[6]   Onco-nephrology: a decalogue [J].
Cosmai, Laura ;
Porta, Camillo ;
Gallieni, Maurizio ;
Perazella, Mark A. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (04) :515-519
[7]   Estimated Glomerular Filtration Rate, All-Cause Mortality and Cardiovascular Diseases Incidence in a Low Risk Population: The MATISS Study [J].
Donfrancesco, Chiara ;
Palleschi, Simonetta ;
Palmieri, Luigi ;
Rossi, Barbara ;
Lo Noce, Cinzia ;
Pannozzo, Fabio ;
Spoto, Belinda ;
Tripepi, Giovanni ;
Zoccali, Carmine ;
Giampaoli, Simona .
PLOS ONE, 2013, 8 (10)
[8]   Cisplatin-induced renal toxicity in elderly people [J].
Duan, ZhiYu ;
Cai, GuangYan ;
Li, JiJun ;
Chen, XiangMei .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
[9]   Association between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Lung Cancer [J].
Helgeson, Scott A. ;
Waddle, Mark R. ;
Burnside, Rebecca C. ;
Debella, Yalew T. ;
Lee, Augustine S. ;
Burger, Charles D. ;
Li, Zhuo ;
Johnson, Patrick W. ;
Patel, Neal M. .
SOUTHERN MEDICAL JOURNAL, 2021, 114 (09) :607-613
[10]   Association of albuminuria and cancer incidence [J].
Jorgensen, Lone ;
Heuch, Ivar ;
Jenssen, Trond ;
Jacobsen, Bjarne K. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (05) :992-998